These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 2424849)

  • 61. European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2017.
    Trautinger F; Eder J; Assaf C; Bagot M; Cozzio A; Dummer R; Gniadecki R; Klemke CD; Ortiz-Romero PL; Papadavid E; Pimpinelli N; Quaglino P; Ranki A; Scarisbrick J; Stadler R; Väkevä L; Vermeer MH; Whittaker S; Willemze R; Knobler R
    Eur J Cancer; 2017 May; 77():57-74. PubMed ID: 28365528
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The role of interferon in the therapy of epidemic Kaposi's sarcoma.
    Krown SE
    Semin Oncol; 1987 Jun; 14(2 Suppl 3):27-33. PubMed ID: 2440110
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Mogamulizumab-induced photosensitivity in patients with mycosis fungoides and other T-cell neoplasms.
    Masuda Y; Tatsuno K; Kitano S; Miyazawa H; Ishibe J; Aoshima M; Shimauchi T; Fujiyama T; Ito T; Tokura Y
    J Eur Acad Dermatol Venereol; 2018 Sep; 32(9):1456-1460. PubMed ID: 29341283
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Mycosis Fungoides Associated with Kaposi's Sarcoma, T-cell Rich B-cell Lymphoma, and T-cell Lymphoma with Angioimmunoblastic Features.
    Samuelov L; Gat A; Bergman R; Sprecher E; Goldberg I
    Acta Dermatovenerol Croat; 2016 Aug; 24(3):218-20. PubMed ID: 27663924
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Common viral infections of the skin and their treatment.
    Smith EB; Raimer SS
    Med Clin North Am; 1982 Jul; 66(4):807-17. PubMed ID: 7098620
    [No Abstract]   [Full Text] [Related]  

  • 66. [Item no 164: malignant lymphoma: cutaneous lymphoma].
    CEDEF
    Ann Dermatol Venereol; 2008 Nov; 135(11 Suppl):F160-2. PubMed ID: 18984207
    [No Abstract]   [Full Text] [Related]  

  • 67. Combined modality therapy with electron-beam irradiation and systemic chemotherapy for cutaneous T-cell lymphomas.
    Bunn PA; Fischmann AB; Schechter GP; Kumar PP; Ihde DC; Cohen MH; Fossieck BE; Gazdar AF; Matthews MJ; Eddy JL; Minna JD
    Cancer Treat Rep; 1979 Apr; 63(4):713-7. PubMed ID: 109208
    [No Abstract]   [Full Text] [Related]  

  • 68. Systemic Treatment Options for Advanced-Stage Mycosis Fungoides and Sézary Syndrome.
    Photiou L; van der Weyden C; McCormack C; Miles Prince H
    Curr Oncol Rep; 2018 Mar; 20(4):32. PubMed ID: 29572582
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The Use of Interferons in the Treatment of Cutaneous T-Cell Lymphoma.
    Spaccarelli N; Rook AH
    Dermatol Clin; 2015 Oct; 33(4):731-45. PubMed ID: 26433845
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [New methods in the treatment of viral skin diseases].
    Söltz-Szöts J
    Z Haut Geschlechtskr; 1971 Oct; 46(20):755-60. PubMed ID: 4329920
    [No Abstract]   [Full Text] [Related]  

  • 71. Interferons.
    Gross G
    Curr Probl Dermatol; 1996; 24():233-46. PubMed ID: 8743275
    [No Abstract]   [Full Text] [Related]  

  • 72. Combination chemotherapy and alpha-interferon in the treatment of Kaposi's sarcoma associated with acquired immune deficiency syndrome.
    Shepherd FA; Evans WK; Garvey B; Read SE; Klein M; Fanning MM; Coates R
    CMAJ; 1988 Oct; 139(7):635-9. PubMed ID: 2458177
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Therapy of cutaneous lymphoma--current practice and future developments.
    Dummer R; Kempf W; Hess Schmid M; Häffner A; Burg G
    Onkologie; 2003 Aug; 26(4):366-72. PubMed ID: 12972705
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Circulating CD4+CD7- lymphocyte burden and rapidity of response: predictors of outcome in the treatment of Sézary syndrome and erythrodermic mycosis fungoides with extracorporeal photopheresis.
    Stevens SR; Baron ED; Masten S; Cooper KD
    Arch Dermatol; 2002 Oct; 138(10):1347-50. PubMed ID: 12374541
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Clinical Trials Referral Resource: Mycosis Fungoides/Sézary Syndrome.
    Cheson BD; Foss FM; Phillips PH
    Oncology (Williston Park); 1995 Jul; 9(7):645-6. PubMed ID: 8924374
    [No Abstract]   [Full Text] [Related]  

  • 76. Interferon treatment of skin cancer in patients with epidermodysplasia verruciformis.
    Blanchet-Bardon C; Puissant A; Lutzner M; Orth G; Nutini MT; Guesry P
    Lancet; 1981 Jan; 1(8214):274. PubMed ID: 6162063
    [No Abstract]   [Full Text] [Related]  

  • 77. Phase II trial of fludarabine phosphate and interferon alfa-2a in advanced mycosis fungoides/Sézary syndrome.
    Foss FM; Ihde DC; Linnoila IR; Fischmann AB; Schechter GP; Cotelingam JD; Steinberg SM; Ghosh BC; Stocker JL; Bastian A
    J Clin Oncol; 1994 Oct; 12(10):2051-9. PubMed ID: 7931473
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Dermatologic therapy: December 1977 through November 1978.
    Coskey RJ
    Cutis; 1979 Jul; 24(1):78-83, 85. PubMed ID: 157851
    [No Abstract]   [Full Text] [Related]  

  • 79. An unusual and fatal case of disseminated cutaneous herpes simplex. Infection in a patient with cutaneous T cell lymphoma (mycosis fungoides).
    Goldgeier MH; Cohen SR; Braverman IM; Stenn KS
    J Am Acad Dermatol; 1981 Feb; 4(2):176-80. PubMed ID: 7217388
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Combined modality therapy for cutaneous T-cell lymphoma.
    Duvic M; Lemak NA; Redman JR; Eifel PJ; Tucker SL; Cabanillas FF; Kurzrock R
    J Am Acad Dermatol; 1996 Jun; 34(6):1022-9. PubMed ID: 8647968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.